Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Ischemic Heart Disease

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 184 articles: HTML format Text format

Single Articles

May 2018
1. MONTONE RA, Niccoli G, Lanza GA, Crea F, et al
   Personalized treatment of myocardial infarction and non-obstructive coronary arteries: an unmet need in a high-risk population.
   Eur Heart J. 2018 May 29. pii: 5020746. doi: 10.1093.
   PubMed     Text format    
   
   
   
2. IBANEZ B, Halvorsen S, Roffi M, Bueno H, et al
   Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task force.
   Eur Heart J. 2018 May 29. pii: 5020748. doi: 10.1093.
   PubMed     Text format    
   
   
   
3. JANSSENS SP, Bogaert J, Zalewski J, Toth A, et al
   Nitric oxide for inhalation in ST-elevation myocardial infarction (NOMI): a multicentre, double-blind, randomized controlled trial.
   Eur Heart J. 2018 May 24. pii: 5003325. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   April 2018
4. MAHMOUD KD, Jolly SS, James S, Dzavik V, et al
   Clinical impact of direct stenting and interaction with thrombus aspiration in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: Thrombectomy Trialists Collaboration.
   Eur Heart J. 2018 Apr 21. pii: 4975836. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   March 2018
5. AUFFRET V, Cottin Y, Leurent G, Gilard M, et al
   Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score.
   Eur Heart J. 2018 Mar 15. pii: 4938779. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
6. DAI J, Xing L, Jia H, Zhu Y, et al
   In vivo predictors of plaque erosion in patients with ST-segment elevation myocardial infarction: a clinical, angiographical, and intravascular optical coherence tomography study.
   Eur Heart J. 2018 Mar 13. pii: 4934156. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   February 2018
7. THYGESEN K, Jaffe AS
   The prognostic impact of periprocedural myocardial infarction and injury.
   Eur Heart J. 2018 Feb 26. pii: 4911112. doi: 10.1093.
   PubMed     Text format    
   
   
   
8. QAYYUM F, Lauridsen BK, Frikke-Schmidt R, Kofoed KF, et al
   Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease.
   Eur Heart J. 2018 Feb 23. pii: 4907930. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
9. 
   euro6.5 million award to study impact of ECMO on myocardial infarction patients.
   Eur Heart J. 2018;39:649.
   PubMed     Text format    
   
   
   
10. WIJNS W, Naber CK
    Reperfusion delay in patients with high-risk ST-segment elevation myocardial infarction: every minute counts, much more than suspected.
    Eur Heart J. 2018 Feb 14. pii: 4855285. doi: 10.1093.
    PubMed     Text format    
    
    
    
11. SCHOLZ KH, Maier SKG, Maier LS, Lengenfelder B, et al
    Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial.
    Eur Heart J. 2018 Feb 14. pii: 4855284. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    January 2018
12. ZEITOUNI M, Silvain J, Guedeney P, Kerneis M, et al
    Periprocedural myocardial infarction and injury in elective coronary stenting.
    Eur Heart J. 2018 Jan 20. pii: 4815728. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
13. LUSCHER TF
    ST-segment elevation myocardial infarction: the new ESC Guidelines.
    Eur Heart J. 2018;39:75-78.
    PubMed     Text format    
    
    
    
14. KIM K, Park SM, Lee K
    Weight gain after smoking cessation does not modify its protective effect on myocardial infarction and stroke: evidence from a cohort study of men.
    Eur Heart J. 2018 Jan 6. pii: 4791953. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    December 2017
15. KOENIG T, Sedding DG, Wester HJ, Derlin T, et al
    Seeing the unseen: post-infarction inflammation in an isolated right ventricular myocardial infarction visualized by combined cardiac magnetic resonance imaging and chemokine receptor CXCR4-targeted molecular imaging.
    Eur Heart J. 2017 Dec 27. pii: 4780241. doi: 10.1093.
    PubMed     Text format    
    
    
    
16. MONTONE RA, Niccoli G, Fracassi F, Russo M, et al
    Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests.
    Eur Heart J. 2017 Dec 8. pii: 4710061. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    October 2017
17. KIM MK, Han K, Kim HS, Park YM, et al
    Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study.
    Eur Heart J. 2017 Oct 21. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
18. THYGESEN K, Jaffe AS
    Detecting myocardial infarction type 2: targetting the right patients.
    Eur Heart J. 2017 Oct 5. doi: 10.1093.
    PubMed     Text format    
    
    
    
19. MANIWA N, Fujino M, Nakai M, Nishimura K, et al
    Anticoagulation combined with antiplatelet therapy in patients with left ventricular thrombus after first acute myocardial infarction.
    Eur Heart J. 2017 Oct 3. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    September 2017
20. KIVIMAKI M, Nyberg ST, Batty GD, Kawachi I, et al
    Long working hours as a risk factor for atrial fibrillation: a multi-cohort study.
    Eur Heart J. 2017;38:2621-2628.
    PubMed     Text format     Abstract available
    
    
    August 2017
21. KOJIMA S, Michikawa T, Ueda K, Sakamoto T, et al
    Asian dust exposure triggers acute myocardial infarction.
    Eur Heart J. 2017 Aug 29. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
22. SZUMMER K, Wallentin L, Lindhagen L, Alfredsson J, et al
    Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014.
    Eur Heart J. 2017 Aug 29. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
23. IBANEZ B, James S, Agewall S, Antunes MJ, et al
    2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European S
    Eur Heart J. 2017 Aug 26. doi: 10.1093.
    PubMed     Text format    
    
    
    
24. KRISTENSEN SD, Maeng M
    Perioperative myocardial infarction: in the twilight zone between surgery and cardiology.
    Eur Heart J. 2017;38:2418-2420.
    PubMed     Text format    
    
    
    
25. SMILOWITZ NR, Gupta N, Guo Y, Berger JS, et al
    Perioperative acute myocardial infarction associated with non-cardiac surgery.
    Eur Heart J. 2017;38:2409-2417.
    PubMed     Text format     Abstract available
    
    
    
26. LASSALE C, Tzoulaki I, Moons KGM, Sweeting M, et al
    Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis.
    Eur Heart J. 2017 Aug 14. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
27. NEUMANN JT, Sorensen NA, Rubsamen N, Ojeda F, et al
    Discrimination of patients with type 2 myocardial infarction.
    Eur Heart J. 2017 Aug 13. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
28. PRESCOT E
    Exercise and case fatality in myocardial infarction.
    Eur Heart J. 2017;38:2324.
    PubMed     Text format    
    
    
    
29. KHAN AR, Golwala H, Tripathi A, Bin Abdulhak AA, et al
    Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis.
    Eur Heart J. 2017 Aug 7. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    July 2017
30. DE WAHA S, Patel MR, Granger CB, Ohman EM, et al
    Relationship between microvascular obstruction and adverse events following primary primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials.
    Eur Heart J. 2017 Jul 28. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
31. HOPEWELL JC, Malik R, Valdes-Marquez E, Worrall BB, et al
    Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke.
    Eur Heart J. 2017 Jul 17. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
32. POTHINENI NVK, Subramany S, Kuriakose K, Shirazi LF, et al
    Infections, atherosclerosis, and coronary heart disease.
    Eur Heart J. 2017 Jul 12. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    June 2017
33. REZVAN A
    Telomeres, oxidative stress, and myocardial infarction.
    Eur Heart J. 2017 Jun 14. doi: 10.1093.
    PubMed     Text format    
    
    
    
34. BARTUNEK J, Wojakowski W
    Intracoronary autologous bone marrow cell transfer after acute myocardial infarction: abort and refocus.
    Eur Heart J. 2017 Jun 13. doi: 10.1093.
    PubMed     Text format    
    
    
    May 2017
35. VIDAL-PETIOT E, Stebbins A, Chiswell K, Ardissino D, et al
    Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial.
    Eur Heart J. 2017 May 27. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
36. DOLL JA, Li S, Chiswell K, Roe MT, et al
    Clopidogrel reloading for patients with acute myocardial infarction already on clopidogrel therapy.
    Eur Heart J. 2017 May 25. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
37. ZITTERMANN A, Ernst JB, Prokop S, Fuchs U, et al
    Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily.
    Eur Heart J. 2017 May 12. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
38. SCHUPKE S, Mehilli J
    Less myocardial scar but greater propensity for heart failure: another gender paradox in myocardial infarction.
    Eur Heart J. 2017 May 5. doi: 10.1093.
    PubMed     Text format    
    
    
    April 2017
39. SINGH-MANOUX A, Fayosse A, Sabia S, Canonico M, et al
    Atrial fibrillation as a risk factor for cognitive decline and dementia.
    Eur Heart J. 2017 Apr 29. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
40. MARGARITIS M, Sanna F, Lazaros G, Akoumianakis I, et al
    Predictive value of telomere length on outcome following acute myocardial infarction: evidence for contrasting effects of vascular vs. blood oxidative stress.
    Eur Heart J. 2017 Apr 24. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
41. WOLLERT KC, Meyer GP, Muller-Ehmsen J, Tschope C, et al
    Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial.
    Eur Heart J. 2017 Apr 19. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
42. CAVALCANTE R, Sotomi Y, Mancone M, Whan Lee C, et al
    Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials.
    Eur Heart J. 2017 Apr 18. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
43. KOSMIDOU I, Redfors B, Selker HP, Thiele H, et al
    Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized t
    Eur Heart J. 2017 Apr 12. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
44. ALFONSO F, Jimenez-Borreguero LJ
    Optimizing dual antiplatelet therapy duration after myocardial infarction: evidence-based, precision, or personalized medicine?
    Eur Heart J. 2017;38:1056-1059.
    PubMed     Text format    
    
    
    
45. VRANCKX P, Frigoli E, Rothenbuhler M, Tomassini F, et al
    Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation.
    Eur Heart J. 2017;38:1069-1080.
    PubMed     Text format     Abstract available
    
    
    
46. GABET A, Danchin N, Juilliere Y, Olie V, et al
    Acute coronary syndrome in women: rising hospitalizations in middle-aged French women, 2004-14.
    Eur Heart J. 2017;38:1060-1065.
    PubMed     Text format     Abstract available
    
    
    
47. PALMERINI T, Della Riva D, Benedetto U, Bacchi Reggiani L, et al
    Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.
    Eur Heart J. 2017;38:1034-1043.
    PubMed     Text format     Abstract available
    
    
    
48. GEBHARD C
    Women and acute coronary syndromes: still up to no good.
    Eur Heart J. 2017;38:1066-1068.
    PubMed     Text format    
    
    
    
49. ONUMA Y, Serruys PW
    Freedom from long DAPT signals the demise of the bare-metal stent.
    Eur Heart J. 2017;38:970-973.
    PubMed     Text format    
    
    
    
50. CARLSSON M
    The impacts on healthcare when coronary angiography as the reference method for diagnostic accuracy of coronary artery disease is replaced by fractional flow reserve!
    Eur Heart J. 2017;38:999-1001.
    PubMed     Text format    
    
    
    March 2017
51. VALGIMIGLI M, Costa F, Lokhnygina Y, Clare RM, et al
    Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial.
    Eur Heart J. 2017;38:804-810.
    PubMed     Text format     Abstract available
    
    
    
52. LI XS, Obeid S, Klingenberg R, Gencer B, et al
    Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
    Eur Heart J. 2017;38:814-824.
    PubMed     Text format     Abstract available
    
    
    
53. JIA H, Dai J, Hou J, Xing L, et al
    Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study).
    Eur Heart J. 2017;38:792-800.
    PubMed     Text format     Abstract available
    
    
    February 2017
54. PASEA L, Chung SC, Pujades-Rodriguez M, Moayyeri A, et al
    Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors.
    Eur Heart J. 2017 Feb 27. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
55. LYALL DM, Celis-Morales CA, Anderson J, Gill JM, et al
    Associations between single and multiple cardiometabolic diseases and cognitive abilities in 474 129 UK Biobank participants.
    Eur Heart J. 2017;38:577-583.
    PubMed     Text format     Abstract available
    
    
    
56. MORTENSEN MB, Nordestgaard BG, Afzal S, Falk E, et al
    ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study.
    Eur Heart J. 2017;38:586-594.
    PubMed     Text format     Abstract available
    
    
    
57. DEFILIPPIS AP, Young R, McEvoy JW, Michos ED, et al
    Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern
    Eur Heart J. 2017;38:598-608.
    PubMed     Text format     Abstract available
    
    
    
58. SHUN-SHIN MJ, Zheng SL, Cole GD, Howard JP, et al
    Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials.
    Eur Heart J. 2017 Feb 21. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
59. BEBB O, Hall M, Fox KA, Dondo TB, et al
    Performance of hospitals according to the ESC ACCA quality indicators and 30-day mortality for acute myocardial infarction: national cohort study using the United Kingdom Myocardial Ischaemia National Audit Project (MINAP) register.
    Eur Heart J. 2017 Feb 20. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
60. MATHUR A, Fernandez-Aviles F, Dimmeler S, Hauskeller C, et al
    The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016.
    Eur Heart J. 2017 Feb 15. doi: 10.1093.
    PubMed     Text format    
    
    
    
61. ODAKA Y, Takahashi J, Tsuburaya R, Nishimiya K, et al
    Plasma concentration of serotonin is a novel biomarker for coronary microvascular dysfunction in patients with suspected angina and unobstructive coronary arteries.
    Eur Heart J. 2017;38:489-496.
    PubMed     Text format     Abstract available
    
    
    
62. KARAKAS M, Schulte C, Appelbaum S, Ojeda F, et al
    Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study.
    Eur Heart J. 2017;38:516-523.
    PubMed     Text format     Abstract available
    
    
    
63. MOTWANI M, Dey D, Berman DS, Germano G, et al
    Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: a 5-year multicentre prospective registry analysis.
    Eur Heart J. 2017;38:500-507.
    PubMed     Text format     Abstract available
    
    
    
64. PRIES AR, Reglin B
    Coronary microcirculatory pathophysiology: can we afford it to remain a black box?
    Eur Heart J. 2017;38:478-488.
    PubMed     Text format     Abstract available
    
    
    
65. NIELSEN LH, Botker HE, Sorensen HT, Schmidt M, et al
    Prognostic assessment of stable coronary artery disease as determined by coronary computed tomography angiography: a Danish multicentre cohort study.
    Eur Heart J. 2017;38:413-421.
    PubMed     Text format     Abstract available
    
    
    
66. VAN DER VALK FM, Kuijk C, Verweij SL, Stiekema LCA, et al
    Increased haematopoietic activity in patients with atherosclerosis.
    Eur Heart J. 2017;38:425-432.
    PubMed     Text format     Abstract available
    
    
    
67. BOURANTAS CV, Jaffer FA, Gijsen FJ, van Soest G, et al
    Hybrid intravascular imaging: recent advances, technical considerations, and current applications in the study of plaque pathophysiology.
    Eur Heart J. 2017;38:400-412.
    PubMed     Text format     Abstract available
    
    
    
68. LEIPSIC J, Blanke P
    Prognostic value of coronary CT angiography: lessons from the West Denmark Cardiac Registry.
    Eur Heart J. 2017;38:422-424.
    PubMed     Text format    
    
    
    
69. CIMATO TR
    Persistent stem cell-driven inflammation in patients with prior MI and stroke.
    Eur Heart J. 2017;38:433-435.
    PubMed     Text format    
    
    
    January 2017
70. ARGACHA JF
    Air pollution and myocardial infarction.
    Eur Heart J. 2017;38:141.
    PubMed     Text format    
    
    
    
71. ROSENGREN A, Ulin K
    Case fatality in coronary heart disease: the art of counting.
    Eur Heart J. 2017;38:181-183.
    PubMed     Text format    
    
    
    
72. FRODERMANN V, Nahrendorf M
    Neutrophil-macrophage cross-talk in acute myocardial infarction.
    Eur Heart J. 2017;38:198-200.
    PubMed     Text format    
    
    
    
73. TOFIELD A
    Myocardial infarction patients are more depressed but receive less antidepressants.
    Eur Heart J. 2017;38:142.
    PubMed     Text format    
    
    
    
74. AGEWALL S, Beltrame JF, Reynolds HR, Niessner A, et al
    ESC working group position paper on myocardial infarction with non-obstructive coronary arteries.
    Eur Heart J. 2017;38:143-153.
    PubMed     Text format    
    
    
    
75. ZEYMER U, Ludman P, Danchin N, Kala P, et al
    The European Society of Cardiology ACCA-EAPCI Registry on ST elevation myocardial infarction.
    Eur Heart J. 2017;38:138-139.
    PubMed     Text format    
    
    
    
76. HORCKMANS M, Ring L, Duchene J, Santovito D, et al
    Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype.
    Eur Heart J. 2017;38:187-197.
    PubMed     Text format    
    
    
    
77. GALLET R, Dawkins J, Valle J, Simsolo E, et al
    Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction.
    Eur Heart J. 2017;38:201-211.
    PubMed     Text format    
    
    
    
78. TOFIELD A
    Cold weather and myocardial infarction.
    Eur Heart J. 2017;38:140.
    PubMed     Text format    
    
    
    December 2016
79. KHANJI MY, Ninan T, Abdul F, Ionescu A, et al
    Congenital 'bifid' left ventricular apex masquerading as pseudo-aneurysm following acute myocardial infarction.
    Eur Heart J. 2016 Dec 27. pii: ehw524. doi: 10.1093.
    PubMed     Text format    
    
    
    
80. JAKOB P, Kacprowski T, Briand-Schumacher S, Heg D, et al
    Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarction.
    Eur Heart J. 2016 Dec 23. pii: ehw563. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
81. BARTUNEK J, Terzic A, Davison BA, Filippatos GS, et al
    Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.
    Eur Heart J. 2016 Dec 23. pii: ehw543. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
82. SCHIELE F
    Quality indicators for acute myocardial infarction.
    Eur Heart J. 2016;37:3549-3550.
    PubMed     Text format    
    
    
    November 2016
83. CREA F, Jaffe AS, Collinson PO, Hamm CW, et al
    Should the 1h algorithm for rule in and rule out of acute myocardial infarction be used universally?
    Eur Heart J. 2016;37:3316-3323.
    PubMed     Text format    
    
    
    
84. 
    Recent hospitalization trends for acute myocardial infarction in Beijing.
    Eur Heart J. 2016;37:3188-3189.
    PubMed     Text format    
    
    
    
85. FERREIRA D, Davies A, Thiruchelvam T, Wark P, et al
    Acute myocardial infarction in disseminated mucormycosis infection.
    Eur Heart J. 2016.
    PubMed     Text format    
    
    
    October 2016
86. 
    Dietary patterns and the secondary prevention of coronary heart disease.
    Eur Heart J. 2016;37:2971-2973.
    PubMed     Text format    
    
    
    September 2016
87. GALLET R, Dawkins J, Valle J, Simsolo E, et al
    Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available
    
    
    
88. RYAN N, Gonzalo N, Freitas-Ferraz A, Martinez P, et al
    Repetitive vasospasm as a cause of plaque rupture and myocardial infarction.
    Eur Heart J. 2016.
    PubMed     Text format    
    
    
    
89. ABRAHAM G, Havulinna AS, Bhalala OG, Byars SG, et al
    Genomic prediction of coronary heart disease.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available
    
    
    August 2016
90. YAMAJI K, Raber L, Zanchin T, Spitzer E, et al
    Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available
    
    
    
91. BABER U, Farkouh ME, Arbel Y, Muntner P, et al
    Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available
    
    
    
92. EISEN A, Cannon CP, Blazing MA, Bohula EA, et al
    The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available
    
    
    July 2016
93. SAHLEN A, Varenhorst C, Lagerqvist B, Renlund H, et al
    Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available
    
    
    
94. VAN HOUT GP, Bosch L, Ellenbroek GH, de Haan JJ, et al
    The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available
    
    
    June 2016
95. TWERENBOLD R, Jaeger C, Rubini Gimenez M, Wildi K, et al
    Impact of high-sensitivity cardiac troponin on use of coronary angiography, cardiac stress testing, and time to discharge in suspected acute myocardial infarction.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available
    
    
    
96. HEUSCH G, Gersh BJ
    The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available
    
    
    
97. PICA S, Ballestrero G, Pistis G, Crimi G, et al
    Acute stent thrombosis unveils two electrocardiogram patterns in a patient with 'De Winter T-waves' anterior myocardial infarction.
    Eur Heart J. 2016.
    PubMed     Text format    
    
    
    May 2016
98. KLEVELAND O, Kunszt G, Bratlie M, Ueland T, et al
    Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available
    
    
    April 2016
99. MORI H, Joner M, Finn AV, Virmani R, et al
    Malapposition: is it a major cause of stent thrombosis?
    Eur Heart J. 2016;37:1217-9.
    PubMed     Text format    
    
    
    
100. PONTONE G
     Anatomy and physiology in ischaemic heart disease: a second honeymoon?
     Eur Heart J. 2016;37:1228-31.
     PubMed     Text format    
     
     
     
101. GAUR S, Ovrehus KA, Dey D, Leipsic J, et al
     Coronary plaque quantification and fractional flow reserve by coronary computed tomography angiography identify ischaemia-causing lesions.
     Eur Heart J. 2016;37:1220-7.
     PubMed     Text format     Abstract available
     
     
     
102. SOUTEYRAND G, Amabile N, Mangin L, Chabin X, et al
     Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry.
     Eur Heart J. 2016;37:1208-16.
     PubMed     Text format     Abstract available
     
     
     
103. LUBBERS M, Dedic A, Coenen A, Galema T, et al
     Calcium imaging and selective computed tomography angiography in comparison to functional testing for suspected coronary artery disease: the multicentre, randomized CRESCENT trial.
     Eur Heart J. 2016;37:1232-43.
     PubMed     Text format     Abstract available
     
     
     
104. SMISETH OA, Torp H, Opdahl A, Haugaa KH, et al
     Myocardial strain imaging: how useful is it in clinical decision making?
     Eur Heart J. 2016;37:1196-207.
     PubMed     Text format     Abstract available
     
     
     
105. GURBEL PA, Tantry US
     Deciding about prolonged ticagrelor therapy in coronary clot formers: an ongoing dilemma.
     Eur Heart J. 2016;37:1143-4.
     PubMed     Text format    
     
     
     
106. TERZIC A, Behfar A
     CardioPulse: Regenerative medicine in the practice of cardiology.
     Eur Heart J. 2016;37:1089-90.
     PubMed     Text format    
     
     
     
107. LUSCHER TF
     Coronary and peripheral interventions: an update.
     Eur Heart J. 2016;37:1085-7.
     PubMed     Text format    
     
     
     
108. PLACIDO R, Almeida AG, Canas da Silva P, Pinto F, et al
     Left main ostial agenesis and right coronary artery occlusion: the importance of the 'Vieussens' arterial ring'.
     Eur Heart J. 2016;37:1170.
     PubMed     Text format    
     
     
     
109. GOTO K, Kasama S, Sato M, Kurabayashi M, et al
     Myocardial scintigraphic evidence of Kounis syndrome: what is the aetiology of acute coronary syndrome?
     Eur Heart J. 2016;37:1157.
     PubMed     Text format    
     
     
     
110. KIRSCHFINK A, Frick M, Reinartz S, Becker M, et al
     An undiagnosed double aortic arch hampers a coronary angiography in a patient with LIMA graft.
     Eur Heart J. 2016;37:1169.
     PubMed     Text format    
     
     
     
111. KIKKERT WJ, Tijssen JG, Piek JJ, Henriques JP, et al
     Challenges in the adjudication of major bleeding events in acute coronary syndrome: a plea for a standardized approach and guidance to adjudication.
     Eur Heart J. 2016;37:1104-12.
     PubMed     Text format    
     
     
     
112. BONACA MP, Bhatt DL, Steg PG, Storey RF, et al
     Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54.
     Eur Heart J. 2016;37:1133-42.
     PubMed     Text format     Abstract available
     
     
     
113. GUTIERREZ JA, Harrington RA, Blankenship JC, Stone GW, et al
     The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX.
     Eur Heart J. 2016;37:1122-30.
     PubMed     Text format     Abstract available
     
     
     
114. MADONNA R, Van Laake LW, Davidson SM, Engel FB, et al
     Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.
     Eur Heart J. 2016.
     PubMed     Text format     Abstract available
     
     
     
115. SINNAEVE PR, Van de Werf F
     Transporting STEMI patients for primary PCI: a long and winding road paved with good intentions?
     Eur Heart J. 2016;37:1041-3.
     PubMed     Text format    
     
     
     
116. TAYLOR J
     CardioPulse. Leaders in cardiovascular medicine today. Peter Libby MD.
     Eur Heart J. 2016;37:1008-9.
     PubMed     Text format    
     
     
     
117. SCHMIDT M, Lamberts M, Olsen AM, Fosboll E, et al
     Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology.
     Eur Heart J. 2016;37:1015-23.
     PubMed     Text format    
     
     
     
118. HAGIKURA A, Goto K, Takebayashi H, Haruta S, et al
     Unintentional extraction of a platinum-chromium everolimus-eluting stent by entanglement with a covered stent.
     Eur Heart J. 2016;37:1083.
     PubMed     Text format    
     
     
     
119. NICCOLI G, Scalone G, Lerman A, Crea F, et al
     Coronary microvascular obstruction in acute myocardial infarction.
     Eur Heart J. 2016;37:1024-33.
     PubMed     Text format     Abstract available
     
     
     
120. CARRICK D, Haig C, Rauhalammi S, Ahmed N, et al
     Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison with contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors.
     Eur Heart J. 2016;37:1044-59.
     PubMed     Text format     Abstract available
     
     
     March 2016
121. LUSCHER TF, Sudano I
     SPRINT: the race for optimal blood pressure control.
     Eur Heart J. 2016;37:937-41.
     PubMed     Text format    
     
     
     
122. LEWIS BS
     CardioPulse: Coronary artery disease from prevention to intervention.
     Eur Heart J. 2016;37:866-7.
     PubMed     Text format    
     
     
     
123. SVENSSON T, Inoue M, Sawada N, Yamagishi K, et al
     Coping strategies and risk of cardiovascular disease incidence and mortality: the Japan Public Health Center-based prospective Study.
     Eur Heart J. 2016;37:890-9.
     PubMed     Text format     Abstract available
     
     
     
124. FERNANDEZ-VEGA A, Vilacosta I, Vedia OA, Pedraja I, et al
     A 'kidnapper' left circumflex coronary artery.
     Eur Heart J. 2016;37:919.
     PubMed     Text format    
     
     
     
125. STOEKENBROEK RM, Boekholdt SM, Luben R, Hovingh GK, et al
     Heterogeneous impact of classic atherosclerotic risk factors on different arterial territories: the EPIC-Norfolk prospective population study.
     Eur Heart J. 2016;37:880-9.
     PubMed     Text format     Abstract available
     
     
     
126. RANTHE MF, Diaz LJ, Behrens I, Bundgaard H, et al
     Association between pregnancy losses in women and risk of atherosclerotic disease in their relatives: a nationwide cohort studydagger.
     Eur Heart J. 2016;37:900-7.
     PubMed     Text format     Abstract available
     
     
     
127. NAHRENDORF M, Swirski FK
     Innate immune cells in ischaemic heart disease: does myocardial infarction beget myocardial infarction?
     Eur Heart J. 2016;37:868-72.
     PubMed     Text format     Abstract available
     
     
     
128. ZHENG SL, Myerson SG, Orchard E
     Partial atrioventricular septal defect presenting in a septuagenarian.
     Eur Heart J. 2016;37:917.
     PubMed     Text format    
     
     
     
129. BONAPACE S, Adamo E, Ciccio C, Chiampan A, et al
     Unusual echocardiographic image of a left circumflex coronary artery with anomalous origin from the right coronary sinus.
     Eur Heart J. 2016;37:792.
     PubMed     Text format    
     
     
     
130. JORGE C, Canas da Silva P, Lousada N, Pinto FJ, et al
     Effort syncope and pencil-point left main coronary artery: cause or unsual finding?
     Eur Heart J. 2016;37:744.
     PubMed     Text format    
     
     
     February 2016
131. ACHENBACH S
     CardioPulse: The future of coronary computer tomography angiography.
     Eur Heart J. 2016;37:661-3.
     PubMed     Text format     Abstract available
     
     
     
132. WATABE H, Sato A, Nishina H, Hoshi T, et al
     Enhancement patterns detected by multidetector computed tomography are associated with microvascular obstruction and left ventricular remodelling in patients with acute myocardial infarction.
     Eur Heart J. 2016;37:684-92.
     PubMed     Text format     Abstract available
     
     
     
133. LUSCHER TF
     Improving prevention: risk scores, imaging, and PCSK9 inhibitors.
     Eur Heart J. 2016;37:499-501.
     PubMed     Text format    
     
     
     
134. KOSKINAS KC, Ughi GJ, Windecker S, Tearney GJ, et al
     Intracoronary imaging of coronary atherosclerosis: validation for diagnosis, prognosis and treatment.
     Eur Heart J. 2016;37:524-35a-c.
     PubMed     Text format     Abstract available
     
     
     
135. GENCER B, Montecucco F, Nanchen D, Carbone F, et al
     Prognostic value of PCSK9 levels in patients with acute coronary syndromes.
     Eur Heart J. 2016;37:546-53.
     PubMed     Text format     Abstract available
     
     
     
136. TADA H, Melander O, Louie JZ, Catanese JJ, et al
     Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history.
     Eur Heart J. 2016;37:561-7.
     PubMed     Text format     Abstract available
     
     
     
137. DIENER HC, Aisenberg J, Ansell J, Atar D, et al
     Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.
     Eur Heart J. 2016.
     PubMed     Text format     Abstract available
     
     
     
138. LECLERCQ C, Dievart F, Ruschitzka F
     Peri-infarct pacing to prevent left reverse remodelling: an unvalidated concept?
     Eur Heart J. 2016;37:494-5.
     PubMed     Text format    
     
     
     
139. DIMARCO A, Mansoubi H, Tanner M
     An unusual cause of left ventricular hypertrophy.
     Eur Heart J. 2016;37:497.
     PubMed     Text format    
     
     
     
140. STONE GW, Chung ES, Stancak B, Svendsen JH, et al
     Peri-infarct zone pacing to prevent adverse left ventricular remodelling in patients with large myocardial infarction.
     Eur Heart J. 2016;37:484-93.
     PubMed     Text format     Abstract available
     
     
     January 2016
141. DANCHIN N, Puymirat E, Schiele F
     Antithrombotic therapy for stable coronary artery disease: the difficult quest for the holy balance.
     Eur Heart J. 2016;37:409-11.
     PubMed     Text format    
     
     
     
142. TOFIELD A
     CardioPulse:Thrombus aspiration does not improve 12-month outcomes.
     Eur Heart J. 2016;37:331-2.
     PubMed     Text format    
     
     
     
143. VERHEUGT FW
     CardioPulse: Triple therapy for percutaneous coronary intervention in atrial fibrillation: a nightmare.
     Eur Heart J. 2016;37:326-7.
     PubMed     Text format    
     
     
     
144. COLOMBO A, Jabbour RJ
     CardioPulse: The future of percutaneous coronary interventions.
     Eur Heart J. 2016;37:322-3.
     PubMed     Text format    
     
     
     
145. PALMERINI T, Stone GW
     Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: conceptual evolution based on emerging evidence.
     Eur Heart J. 2016;37:353-64.
     PubMed     Text format     Abstract available
     
     
     
146. GURBEL PA, Tantry US
     CardioPulse: Platelet inhibitors and their differences.
     Eur Heart J. 2016;37:323-6.
     PubMed     Text format    
     
     
     
147. LUSCHER TF
     The search for optimal dual antiplatelet therapy after PCI: fine-tuning of initiation and duration.
     Eur Heart J. 2016;37:319-21.
     PubMed     Text format    
     
     
     
148. ROE MT, Cyr DD, Eckart D, Schulte PJ, et al
     Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome.
     Eur Heart J. 2016;37:412-22.
     PubMed     Text format     Abstract available
     
     
     
149. MARTI D, Moya JL, Cuevas A, Zamorano JL, et al
     A rare cause of tough coronary occlusion.
     Eur Heart J. 2016;37:343.
     PubMed     Text format    
     
     
     
150. AL-LAMEE R, Davies JE, Gerber R
     An unusual complication of coronary angiography via the radial approach.
     Eur Heart J. 2016;37:385.
     PubMed     Text format    
     
     
     
151. MAGNANI G, Storey RF, Steg G, Bhatt DL, et al
     Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial.
     Eur Heart J. 2016;37:400-8.
     PubMed     Text format     Abstract available
     
     
     
152. HELFT G, Steg PG, Le Feuvre C, Georges JL, et al
     Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial.
     Eur Heart J. 2016;37:365-74.
     PubMed     Text format     Abstract available
     
     
     
153. UDELL JA, Bonaca MP, Collet JP, Lincoff AM, et al
     Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials.
     Eur Heart J. 2016;37:390-9.
     PubMed     Text format     Abstract available
     
     
     
154. MONTALESCOT G, Sabatine MS
     Oral dual antiplatelet therapy: what have we learnt from recent trials?
     Eur Heart J. 2016;37:344-52.
     PubMed     Text format     Abstract available
     
     
     
155. HAFLIGER M, Weilenmann D, Rickli H, Maeder MT, et al
     Recurrent left anterior descending artery spasm causing transmural ischaemia treated with stenting.
     Eur Heart J. 2016;37:364.
     PubMed     Text format    
     
     
     
156. TOFIELD A
     CardioPulse: Exercise and stop smoking to improve depression after myocardial infarction.
     Eur Heart J. 2016;37:214-5.
     PubMed     Text format    
     
     
     
157. NICHOLLS M
     CardioPulse: Cyclosporine to reduce myocardial infarction injury?
     Eur Heart J. 2016;37:210-1.
     PubMed     Text format    
     
     
     
158. LANZER C, Lanzer P
     CardioPulse: Angina pectoris revisited.
     Eur Heart J. 2016;37:215.
     PubMed     Text format    
     
     
     
159. MOTOVSKA Z
     CardioPulse: Quality measures in acute coronary syndromes.
     Eur Heart J. 2016;37:209-10.
     PubMed     Text format    
     
     
     
160. ROFFI M, Patrono C
     CardioPulse: 'Ten Commandments' of 2015 European Society of Cardiology Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation (NSTE-ACS).
     Eur Heart J. 2016;37:208.
     PubMed     Text format    
     
     
     
161. ROFFI M, Patrono C, Zamorano JL
     CardioPulse: What's new in the 2015 European Society of Cardiology Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
     Eur Heart J. 2016;37:206-7.
     PubMed     Text format    
     
     
     
162. LUSCHER TF
     The management of acute coronary syndromes: towards optimal treatment of STEMI and non-STEMI.
     Eur Heart J. 2016;37:203-5.
     PubMed     Text format    
     
     
     
163. MONTALESCOT G, Crea F
     The year in cardiology 2015: acute coronary syndromes.
     Eur Heart J. 2016;37:221-8.
     PubMed     Text format    
     
     
     
164. KUBICA J, Adamski P, Ostrowska M, Sikora J, et al
     Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial.
     Eur Heart J. 2016;37:245-52.
     PubMed     Text format     Abstract available
     
     
     
165. CHOUDRY F, Hamshere S, Saunders N, Veerapen J, et al
     A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trialdagger.
     Eur Heart J. 2016;37:256-63.
     PubMed     Text format     Abstract available
     
     
     
166. SABATE M, Windecker S, Iniguez A, Okkels-Jensen L, et al
     Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.
     Eur Heart J. 2016;37:229-40.
     PubMed     Text format     Abstract available
     
     
     
167. KUMAR V, Varghese MJ, Raveendran S, George OK, et al
     Pseudoaneurysm following transradial coronary angiogram.
     Eur Heart J. 2016;37:252.
     PubMed     Text format    
     
     
     
168. ROFFI M, Patrono C, Collet JP, Mueller C, et al
     2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation
     Eur Heart J. 2016;37:267-315.
     PubMed     Text format    
     
     
     
169. HEUSCH G, Gersh BJ
     ERICCA and RIPHeart: two nails in the coffin for cardioprotection by remote ischemic conditioning? Probably not!
     Eur Heart J. 2016;37:200-2.
     PubMed     Text format    
     
     
     
170. KOMAJDA M, Weidinger F, Kerneis M, Cosentino F, et al
     EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT).
     Eur Heart J. 2016;37:152-60.
     PubMed     Text format     Abstract available
     
     
     
171. SALEH Y, AlMaghraby A, Haggag A, Hammad B, et al
     An inferior vena cava filter causing perforation with all six legs.
     Eur Heart J. 2016;37:163.
     PubMed     Text format    
     
     
     
172. STEG PG, Serruys PW, Abdelghani M, Wijns W, et al
     The year in cardiology 2015: coronary intervention.
     Eur Heart J. 2016.
     PubMed     Text format    
     
     
     December 2015
173. KARIMI GALOUGAHI K, Zalewski A, Leon MB, Karmpaliotis D, et al
     Optical coherence tomography-guided percutaneous coronary intervention in pre-terminal chronic kidney disease with no radio-contrast administration.
     Eur Heart J. 2015.
     PubMed     Text format    
     
     
     
174. RYAN N, Terol B, Grande-Ingelmo JM, Escaned J, et al
     Persistent post percutaneous coronary intervention angina investigated with invasive physiological testing.
     Eur Heart J. 2015.
     PubMed     Text format    
     
     
     
175. LUSCHER TF
     Deciding on coronary intervention: which lesion, which stent?
     Eur Heart J. 2015;36:3301-3.
     PubMed     Text format    
     
     
     November 2015
176. MANCIA G, Kjeldsen SE, Zappe DH, Holzhauer B, et al
     Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.
     Eur Heart J. 2015.
     PubMed     Text format     Abstract available
     
     
     
177. MAURI L, Elmariah S, Yeh RW, Cutlip DE, et al
     Causes of late mortality with dual antiplatelet therapy after coronary stents.
     Eur Heart J. 2015.
     PubMed     Text format     Abstract available
     
     
     September 2015
178. ZIMMERMANN FM, Ferrara A, Johnson NP, van Nunen LX, et al
     Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial.
     Eur Heart J. 2015.
     PubMed     Text format     Abstract available
     
     
     
179. FOX K, Ford I, Steg PG, Tardif JC, et al
     Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study.
     Eur Heart J. 2015.
     PubMed     Text format     Abstract available
     
     
     August 2015
180. PRIORI SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, et al
     2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the Eu
     Eur Heart J. 2015.
     PubMed     Text format    
     
     
     
181. BARBASH IM, Barbanti M, Webb J, Molina-Martin De Nicolas J, et al
     Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation.
     Eur Heart J. 2015.
     PubMed     Text format     Abstract available
     
     
     
182. LEITMAN M, Shmueli R, Rubchevsky V, Hendler A, et al
     A 45-year-old woman with chest pain after coronary stenting.
     Eur Heart J. 2015.
     PubMed     Text format    
     
     
     
183. WIJNS W, Shite J, Jones MR, Lee SW, et al
     Optical coherence tomography imaging during percutaneous coronary intervention impacts physician decision-making: ILUMIEN I study.
     Eur Heart J. 2015.
     PubMed     Text format     Abstract available
     
     
     June 2015
184. YSSAP J, Lebreton G, Hoen B, Larifla L, et al
     Infected left ventricular thrombus revealing an unrecognized coronary dissection after blunt chest trauma, treated with emergency heart transplantation.
     Eur Heart J. 2015.
     PubMed     Text format    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: